Does CBD Provide Benefits For Seizures And Epilepsy?
CBD is one of many powerful cannabinoids found in hemp known for helping to support our body and mind. Here at Healing Dragon CBD we do not intend to make unfounded medical claims about the health benefits of CBD. The FDA has not confirmed that CBD cures, treats, or prevents any diseases or conditions. Before reading this article please take a moment to read our full disclosure statement.
CBD has achieved a lot of fame because of the astonishing results it has provided those suffering epilepsy and other seizure disorders. In fact the drug Epidiolex is the only FDA approved drug derived from cannabidiol (CBD). This is the first and only treatment that has proven to reduce seizures in people living with Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS), two rare epileptic disorders.
But flashing back we can see that using CBD as a treatment for seizures has been researched since the 1970s and 1980s. The results on human and animal studies were positive although the research behind them were not considered scientifically concrete. A few studies show that endocannabinoid deficiency may contribute to the development of seizures.
There have been ten centers in the U.S. that have studied the effectiveness of cannabis to treat epilepsy since 2013. The majority of these studies used doses between 2mg and 5mg of CBD per day. A literature review of these studies showed minimal side effects including drowsiness, diarrhea, and decreased appetite but the treatment results were positive. The take away was that further research would be needed to fully understand why CBD is so effective in controlling seizures.
In a small study in Colorado 11 of 11 participants (100%) reported reduction in weekly frequency of motor type seizures. With 8 of the 11 showing nearly 100% reduction of seizures with CBD treatment. At the UCLA Medical Center a survey conducted with 117 parents showed 85% reported lower frequencies of seizures in their children. And 14% said their children were free of seizures by using cannabidiol. A 2017 review confirmed antiepileptic properties of CBD with Phase III trials of Epidiolex providing “pivotal evidence of clinical efficacy” of CBD.
While Epidiolex was approved by the FDA in mid-2018 the DEA is still considering reclassification of CBD from a Schedule I to a Schedule II or III controlled substance. This will need to happen before Epidiolex is available on the national market. Fortunately, in the meantime you can purchase CBD online as an antiepileptic treatment and other benefits of cannabidiol.